Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
6600 participants
INTERVENTIONAL
2024-02-05
2028-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community-Driven Cervical Cancer Prevention in Western Kenya
NCT02124252
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
NCT07294066
Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa
NCT05414097
A New Approach to Cervical Cancer Prevention in Kenya
NCT03942705
Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya
NCT03514459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CATSystem Intervention
Participants enrolled at intervention sites will receive CATSytem-supported cervical cancer screening and treatment services. Interventions received will include: text messages to patients and algorithm-driven alerts to providers when guideline-adherent cervical cancer screening and treatment services are required including: initial and follow up cervical cancer screening, on site treatment, and referral tracking.
Cancer Tracking System (CATSystem)
The CATSystem provider dashboard highlights patients with overdue services or those in need of outreach and sends automated, customized texts to support screening and treatment follow-up per national guidelines. Points of intervention and alerts include: cervical cancer screening and treatment counseling, initial and follow up cervical cancer screening per national guidelines, treatment for precancer and cancer, referral tracking and follow up. In addition, the CATSystem can securely store images of the cervix taken with colposcopes to allow for remote expert consultation if needed to correctly diagnose a patient or can be reviewed at clinical team meetings for input. Primary goals of the CATSystem are to increase rates of guideline-adherent cervical cancer screening/ rescreening and improve guideline-adherent treatment, referral, and follow-up rates of women with positive screens.
Standard of care
Participants enrolled at control sites will receive standard of care PMTCT services, with no CATSystem tracking or follow up
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cancer Tracking System (CATSystem)
The CATSystem provider dashboard highlights patients with overdue services or those in need of outreach and sends automated, customized texts to support screening and treatment follow-up per national guidelines. Points of intervention and alerts include: cervical cancer screening and treatment counseling, initial and follow up cervical cancer screening per national guidelines, treatment for precancer and cancer, referral tracking and follow up. In addition, the CATSystem can securely store images of the cervix taken with colposcopes to allow for remote expert consultation if needed to correctly diagnose a patient or can be reviewed at clinical team meetings for input. Primary goals of the CATSystem are to increase rates of guideline-adherent cervical cancer screening/ rescreening and improve guideline-adherent treatment, referral, and follow-up rates of women with positive screens.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* access to a cell phone,
* presenting for cervical cancer screening at a study hospital.
Exclusion Criteria
* incarcerated patients,
* women who study staff feel are unable to provide written informed consent due to impaired capacity.
16 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Global Health Innovations
OTHER
DARTNet Institute
OTHER_GOV
San Diego State University
OTHER
University of Michigan
OTHER
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Finocchario-Kessler, PhD
Role: PRINCIPAL_INVESTIGATOR
Univer
Natabhona Mabachi, PhD
Role: PRINCIPAL_INVESTIGATOR
DARTNet Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akala Health Center
Akala, , Kenya
Bondo Referral Hospital
Bondo, , Kenya
Alupe Sub-County Hospital
Busia, , Kenya
Busia County Referral Hospital
Busia, , Kenya
Khunyangu Sub-County Hospital
Busia, , Kenya
Matayos Health Center
Busia, , Kenya
Port Victoria Sub-County Hospital
Busia, , Kenya
Nambale Sub-County Hospital
Siaya, , Kenya
Yala Sub-County Hospital
Siaya, , Kenya
Ukwala Sub-County Hospital
Ukwala, , Kenya
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.